Combined OX40 ligation plus CTLA-4 blockade: More than the sum of its parts

por Linch, Stefanie N, Redmond, William L
Publicado 2014

How do I steer this thing? Using dendritic cell targeted vaccination to more effectively guide the antitumor immune response with combination immunotherapy

por Linch, Stefanie N., Redmond, William L.
Publicado 2016

Combinatorial immunotherapeutic approaches to restore the function of anergic tumor-reactive cytotoxic CD8(+) T cells

por Redmond, William L., Linch, Stefanie N.
Publicado 2016

Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity

por Redmond, William L, Linch, Stefanie N, Kasiewicz, Melissa J
Publicado 2013

Combination OX40 agonism/CTLA-4 blockade with vaccination reverses anergy and primes tumor-specific CD8 T cells in mice with spontaneous prostate cancer

por Linch, Stefanie N, Kasiewicz, Melissa J, Redmond, William L
Publicado 2013

OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal

por Linch, Stefanie N., McNamara, Michael J., Redmond, William L.
Publicado 2015

Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsi...

por Cohan, Stanley L., Lucassen, Elisabeth B., Romba, Meghan C., Linch, Stefanie N.
Publicado 2019

Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature

por Linch, Stefanie, Kasiewicz, Melissa J, McNamara, Michael, Hilgart, Ian, Farhad, Mohammad, Redmond, William
Publicado 2015

Common gamma chain (γc) cytokines differentially potentiate TNFR family signaling in antigen-activated CD8(+) T cells

por McNamara, Michael J, Kasiewicz, Melissa J, Linch, Stefanie N, Dubay, Christopher, Redmond, William L
Publicado 2014

Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T cell anergy and promotes survival in tumor-bearing mice

por Linch, Stefanie, Kasiewicz, Melissa J, McNamara, Michael, Hilgart-Martiszus, Ian, Farhad, Mohammad, Redmond, William
Publicado 2015

Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity

por Sturgill, Elizabeth R., Rolig, Annah S., Linch, Stefanie N., Mick, Courtney, Kasiewicz, Melissa J., Sun, Zhaoyu, Traber, Peter G., Shlevin, Harold, Redmond, William L.
Publicado 2021

Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases

por Page, David B., Beal, Kathryn, Linch, Stefanie N., Spinelli, Kateri J., Rodine, Micaela, Halpenny, Darragh, Modi, Shanu, Patil, Sujata, Young, Robert J., Kaley, Thomas, Merghoub, Taha, Redmond, David, Wong, Phillip, Barker, Christopher A., Diab, Adi, Norton, Larry, McArthur, Heather L.
Publicado 2022